Meeting
2018 Genitourinary Cancers Symposium
Defining the DNA damage repair (DDR) genomic landscape of urothelial carcinoma of the bladder (UCB).
Authors
Shawn Dason
Memorial Sloan Kettering Cancer Center, New York, NY
Shawn Dason , Victor McPherson , Min Yuen Teo , Sumit Isharwal , François Audenet , Aditya Bagrodia , Eugene K. Cha , Michael F. Berger , Ahmet Zehir , Nikolaus Schultz , Dean F. Bajorin , Jonathan E. Rosenberg , Hikmat Al-Ahmadie , Bernard H. Bochner , Eugene J. Pietzak , David B. Solit , Gopa Iyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 502)
DOI
10.1200/JCO.2018.36.6_suppl.502
Abstract #
502
Poster Bd #
K9
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A phase II study of gemcitabine plus cisplatin chemotherapy in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterious DNA damage response (DDR) gene alterations (Alliance A031701).
First Author: Gopa Iyer
First Author: Amin Nassar
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss
First Author: Francois Audenet